Cur also promotes the anticancer activity of (-)-epicatechin against NSCLC by potentiating the expression of GADD153 and GADD45 genes, causing apoptosis and inhibiting cell proliferation [100]. The gene discussed is DDIT3; the disease is non-small cell lung carcinoma.